The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Regan William J. since 2013.
The trader's CIK number is 1559381.
At the time of the last reporting, Regan William J. was the SVP-Global Regulatory Strategy of Navidea Biopharmaceuticals, Inc.. (stock ticker symbol NAVB).
Also see all insider trading activities at Navidea Biopharmaceuticals, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | NAVB | 20,000 | $10,580 | 0 | $0 | 0 | $0 |
| 2014 | NAVB | 5,000 | $7,135 | 0 | $0 | 0 | $0 |
| 2013 | NAVB | 5,000 | $13,550 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-06-29 | NAVB | Buy | 20,000 | .53 | 10,580 |
| 2014-05-12 | NAVB | Buy | 5,000 | 1.43 | 7,135 |
| 2013-03-15 | NAVB | Buy | 5,000 | 2.71 | 13,550 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Regan William J. (SVP-Global Regulatory Strategy of Navidea Biopharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.